Spillover Effects of Opioid Abuse on Skilled Human Capital and Innovation Activity

References

• Aliprantis D, Fee K, Schweitzer M (2019) Opioids and the labor market. Working Paper No. 18-07R2, Federal Reserve Bank of Cleveland, Cleveland.Google Scholar
• Alpert A, Powell D, Pacula RL (2018) Supply-side drug policy in the presence of substitutes: Evidence from the introduction of abuse-deterrent opioids. Amer. Econom. J.: Econom. Policy 10(4):1–35.Crossref, Google Scholar
• Alpert AE, Evans WN, Lieber EMJ, Powell D (2022) Origins of the opioid crisis and its enduring impacts. Quart. J. Econom. 137(2):1139–1179.Crossref, Google Scholar
• Balsmeier B, Fleming L, Marx M, Shin SR (2020) Skilled human capital and high-growth entrepreneurship: Evidence from inventor inflows. NBER Working Paper No. 27605, National Bureau of Economic Research, Cambridge, MA.Google Scholar
• Barnett ML, Olenski AR, Jena AB (2017) Opioid-prescribing patterns of emergency physicians and risk of long-term use. New England J. Medicine 376(4):663–673.Crossref, Google Scholar
• Barnett ML, Zhao X, Fine MJ, Thorpe CT, Sileanu FE, Cashy JP, Mor MK, et al. (2019) Emergency physician opioid prescribing and risk of long-term use in the Veterans Health Administration: An observational analysis. J. General Internal Medicine 34:1522–1529.Crossref, Google Scholar
• Beheshti D (2019) Adverse health effects of abuse-deterrent opioids: Evidence from the reformulation of OxyContin. Health Econom. 28(12):1449–1461.Crossref, Google Scholar
• Beheshti D (2023) The impact of opioids on the labor market: Evidence from drug rescheduling. J. Human Resources 58(6):2001–2041.Crossref, Google Scholar
• Beheshti D, Neller S (2025) What causes geographic variation in prescription drug spending? Evidence from physician migration. RAND J. Econom. Forthcoming.Google Scholar
• Bernstein S (2015) Does going public affect innovation? J. Finance 70(4):1365–1403.Crossref, Google Scholar
• Bernstein S, Townsend RR, Xu T (2024) Flight to safety: How economic downturns affect talent flows to startups. Rev. Financial Stud. 37(3):837–881. Google Scholar
• Bernstein S, Colonnelli E, Malacrino D, McQuade T (2022) Who creates new firms when local opportunities arise? J. Financial Econom. 143(1):107–130.Crossref, Google Scholar
• Case A, Deaton A (2015) Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proc. Natl. Acad. Sci. USA 112(49):15078–15083.Crossref, Google Scholar
• Chen C, Huang Q, Shi C, Yuan T (2024) Opioid epidemic and corporate innovation. J. Corporate Finance 86:102586.Crossref, Google Scholar
• Chen C, Petterson S, Phillips R, Bazemore A, Mullan F (2014) Spending patterns in region of residency training and subsequent expenditures for care provided by practicing physicians for Medicare beneficiaries. JAMA 312(22):2385–2393.Crossref, Google Scholar
• Cho D, Garcia D, Montes J, Weingarden A (2022) Labor market effects of the oxycodone-heroin epidemic. Finance and Economics Discussion Series 2021-025, Board of Governors of the Federal Reserve System, Washington, DC.Google Scholar
• Cicero TJ, Ellis MS (2015) Abuse-deterrent formulations and the prescription opioid abuse epidemic in the United States: Lessons learned from OxyContin. JAMA Psychiatry 72(5):424–430.Crossref, Google Scholar
• Cicero TJ, Inciardi JA, Muñoz A (2005) Trends in abuse of OxyContin and other opioid analgesics in the United States: 2002-2004. J. Pain 6(10):662–672.Crossref, Google Scholar
• Cohn JB, Liu Z, Wardlaw MI (2022) Count (and count-like) data in finance. J. Financial Econom. 146(2):529–551.Crossref, Google Scholar
• Cornaggia K, Hund J, Nguyen G, Ye Z (2022) Opioid crisis effects on municipal finance. Rev. Financial Stud. 35(4):2019–2066.Crossref, Google Scholar
• Cornaggia J, Mao Y, Tian X, Wolfe B (2015) Does banking competition affect innovation? J. Financial Econom. 115(1):189–209.Crossref, Google Scholar
• Currie J, Schwandt H (2021) The opioid epidemic was not caused by economic distress but by factors that could be more rapidly addressed. Ann. Amer. Acad. Political Soc. Sci. 695(1):276–291.Crossref, Google Scholar
• Currie J, Jin J, Schnell M (2019) US employment and opioids: Is there a connection? Res. Labor Econom. 47:253–280. Crossref, Google Scholar
• Custodio C, Cvijanovic D, Wiedemann M (2025) Opioid crisis and real estate prices. J. Financial Quant. Anal. Forthcoming.Google Scholar
• Cutler D, Skinner JS, Stern AD, Wennberg D (2019) Physician beliefs and patient preferences: A new look at regional variation in health care spending. Amer. Econom. J.: Econom. Policy 11(1):192–221.Crossref, Google Scholar
• Davda LS, Gallagher JE, Radford DR (2018) Migration motives and integration of international human resources of health in the United Kingdom: Systematic review and meta-synthesis of qualitative studies using framework analysis. Human Resources Health 16:27.Crossref, Google Scholar
• Dougal C, Parsons CA, Titman S (2022) The geography of value creation. Rev. Financial Stud. 35(9):4201–4248.Crossref, Google Scholar
• Duan WR, Hand DJ (2021) Association between opioid overdose death rates and educational attainment – United States, 2010–2019. Preventive Medicine 153:106785.Crossref, Google Scholar
• Eichmeyer S, Zhang J (2022) Pathways into opioid dependence: Evidence from practice variation in emergency departments. Amer. Econom. J.: Appl. Econom. 14(4):271–300.Crossref, Google Scholar
• Eichmeyer S, Zhang J (2023) Primary care providers’ influence on opioid use and its adverse consequences. J. Public Econom. 217(4):104784.Crossref, Google Scholar
• Evans MF, Harris MC, Kessler LM (2022) The hazards of unwinding the prescription opioid epidemic: Implications for child maltreatment. Amer. Econom. J.: Econom. Policy 14(4):192–231.Crossref, Google Scholar
• Evans WN, Lieber EM, Power P (2019) How the reformulation of OxyContin ignited the heroin epidemic. Rev. Econom. Statist. 101(1):1–15.Crossref, Google Scholar
• Friedman M (1994) Purdue Interoffice Memorandum: Product Pipeline and Strategy. Discovery in KY vs Purdue Pharma. Deposition Exhibit, https://www.industrydocuments.ucsf.edu/docs/fqcf0232/.Google Scholar
• GAO (2003) OxyContin abuse and diversion and efforts to address the problem. Report to Congressional Requesters No. GAO-04-110, U.S. General Accounting Office, Washington, DC.Google Scholar
• Greenwood MJ (1997) Internal migration in developed countries. Rosenzweig MR, Stark O, eds. Handbook of Population and Family Economics, vol. 1 (Elsevier, Amsterdam), 647–720.Crossref, Google Scholar
• Harris MC, Kessler LM, Murray MN, Glenn B (2020) Prescription opioids and labor market pains: The effect of schedule II opioids on labor force participation and unemployment. J. Human Resources 55(4):1319–1364.Crossref, Google Scholar
• Hombert J, Matray A (2017) The real effects of lending relationships on innovative firms and inventor mobility. Rev. Financial Stud. 30(7):2413–2445.Crossref, Google Scholar
• Hsu PH, Tian X, Xu Y (2014) Financial development and innovation: Cross-country evidence. J. Financial Econom. 112(1):116–135.Crossref, Google Scholar
• Jansen M (2022) Spillover effects of the opioid epidemic on consumer finance. J. Financial Quant. Anal. 58(6):2365–2386.Crossref, Google Scholar
• Kaplan J (2023) Jacob Kaplan’s concatenated files: Uniform crime reporting program data: Offenses known and clearances by arrest (Return A), 1960-2022: ucr_offenses_known_monthly_1960_2022_rds.zip. Inter-university Consortium for Political and Social Research [distributor], Ann Arbor, MI. Accessed October 26, 2023, https://doi.org/10.3886/E100707V20-143948.Google Scholar
• Kerr SP, Kerr W, Özden Ç, Parsons C (2016) Global talent flows. J. Econom. Perspect. 30(4):83–106.Crossref, Google Scholar
• Kerr SP, Kerr W, Özden Ç, Parsons C (2017) High-skilled migration and agglomeration. Annual Rev. Econom. 9:201–234.Crossref, Google Scholar
• Kogan L, Papanikolaou D, Seru A, Stoffman N (2017) Technological innovation, resource allocation, and growth. Quart. J. Econom. 132(2):665–712.Crossref, Google Scholar
• Krueger AB (2017) Where have all the workers gone? An inquiry into the decline of the US labor participation rate. Brookings Papers Econom. Activity 2017(2):1–81.Crossref, Google Scholar
• Labonté R, Sanders D, Mathole T, Crush J, Chikanda A, Dambisya Y, Runnels V, et al. (2015) Health worker migration from South Africa: Causes, consequences and policy responses. Human Resources Health 13:92.Crossref, Google Scholar
• Lerner J, Seru A (2022) The use and misuse of patent data: Issues for finance and beyond. Rev. Financial Stud. 35(6):2667–2704.Crossref, Google Scholar
• López Cruz IG (2019) Policing, schooling and human capital accumulation. J. Econom. Behav. Organ. 159:572–597.Crossref, Google Scholar
• Louca C, Michaely R, Petmezas D (2024) Spillover effects of the opioid epidemic on labor and innovation. Preprint, submitted December 14, https://doi.org/10.2139/ssrn.4299320.Google Scholar
• Maclean JC, Mallatt J, Ruhm CJ, Simon K (2021) Economic studies on the opioid crisis: Costs, causes, and policy responses. Oxford Research Encyclopedia of Economics and Finance (Oxford University Press, Oxford, UK).Crossref, Google Scholar
• Maltz MD, Targonski J (2002) A note on the use of county-level UCR data. J. Quant. Criminology 18:297–318.Crossref, Google Scholar
• Matray A (2021) The local innovation spillovers of listed firms. J. Financial Econom. 141(2):395–412.Crossref, Google Scholar
• Moretti E (2012) The New Geography of Jobs (Houghton Mifflin Harcourt, New York).Google Scholar
• Moretti E, Wilson DJ (2017) The effect of state taxes on the geographical location of top earners: Evidence from star scientists. Amer. Econom. Rev. 107(7):1858–1903.Crossref, Google Scholar
• Ouimet P, Simintzi E, Ye K (2024) The impact of the opioid crisis on firm value and investment. Rev. Financial Stud. 38(5):1291–1332.Crossref, Google Scholar
• Park S, Powell D (2021) Is the rise in illicit opioids affecting labor supply and disability claiming rates? J. Health Econom. 76:102430.Crossref, Google Scholar
• Powell D, Pacula RL (2021) The evolving consequences of oxycontin reformulation on drug overdoses. Amer. J. Health Econom. 7(1):41–67.Crossref, Google Scholar
• Ruhm CJ (2019) Drivers of the fatal drug epidemic. J. Health Econom. 64:25–42.Crossref, Google Scholar
• Schnell M, Currie J (2018) Addressing the opioid epidemic: Is there a role for physician education? Amer. J. Health Econom. 4(3):383–410.Crossref, Google Scholar
• Stoffman N, Woeppel M, Yavuz MD (2022) Small innovators: No risk, no return. J. Accounting Econom. (7):101492.Crossref, Google Scholar
• Tu P (2017) Quasi-experimental evidence of physician effects. Working paper, Harvard University, Cambridge, MA.Google Scholar
• Van Zee A (2009) The promotion and marketing of oxycontin: Commercial triumph, public health tragedy. Amer. J. Public Health 99:221–227.Crossref, Google Scholar